These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18068276

  • 1. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
    Brotherton JM.
    Vaccine; 2008 Jan 10; 26(2):250-6. PubMed ID: 18068276
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [Abstract] [Full Text] [Related]

  • 3. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
    Syrjänen KJ.
    Scand J Infect Dis Suppl; 2009 Aug 19; 108():2-32. PubMed ID: 19939209
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, Louie KS, Quinn MA.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus types in invasive cervical cancer specimens from Turkey.
    Usubütün A, Alemany L, Küçükali T, Ayhan A, Yüce K, de Sanjosé S, Font R, Lloveras B, Klaustermeier J, Quint W, Muñoz N, Bosch FX.
    Int J Gynecol Pathol; 2009 Nov 19; 28(6):541-8. PubMed ID: 19851201
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R, Shin HR, Kim YT, Song YS, Sasagawa T, Inoue M, Park JS.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [Abstract] [Full Text] [Related]

  • 7. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep 19; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

  • 8. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML, Tabrizi SN, Phillips S, Pyman J, Cornall AM, Lambie N, Anderson L, Cummings M, Payton D, Scurry JP, Newman M, Sharma R, Saville M, Garland SM.
    Int J Cancer; 2017 Oct 15; 141(8):1576-1584. PubMed ID: 28677147
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC.
    Cytopathology; 2009 Aug 15; 20(4):249-55. PubMed ID: 19018810
    [Abstract] [Full Text] [Related]

  • 10. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):321-30. PubMed ID: 19124515
    [Abstract] [Full Text] [Related]

  • 11. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
    Berlin Grace VM.
    Indian J Cancer; 2009 Jan 15; 46(3):203-7. PubMed ID: 19574671
    [Abstract] [Full Text] [Related]

  • 12. Human papilloma viruses and cancer in the post-vaccine era.
    Galani E, Christodoulou C.
    Clin Microbiol Infect; 2009 Nov 15; 15(11):977-81. PubMed ID: 19874381
    [Abstract] [Full Text] [Related]

  • 13. New advances in vaccine technology and improved cervical cancer prevention.
    Huh WK, Kendrick JE, Alvarez RD.
    Obstet Gynecol; 2007 May 15; 109(5):1187-92. PubMed ID: 17470604
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP, Li N, Smith JS, Qiao YL.
    Int J STD AIDS; 2008 Feb 15; 19(2):106-11. PubMed ID: 18334063
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
    Alemany L, Pérez C, Tous S, Llombart-Bosch A, Lloveras B, Lerma E, Guarch R, Andújar M, Pelayo A, Alejo M, Ordi J, Klaustermeier J, Velasco J, Guimerà N, Clavero O, Castellsagué X, Quint W, Muñoz N, Bosch FX, de Sanjosé S, Spanish study group RIS HPV TT.
    Gynecol Oncol; 2012 Mar 15; 124(3):512-7. PubMed ID: 22119990
    [Abstract] [Full Text] [Related]

  • 16. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H.
    Bull Acad Natl Med; 2007 Dec 15; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [Abstract] [Full Text] [Related]

  • 17. Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?
    Dillner J, Brown DR.
    Expert Rev Mol Med; 2004 Apr 20; 6(9):1-21. PubMed ID: 15096282
    [Abstract] [Full Text] [Related]

  • 18. [Anal cancer and human papillomaviruses: a perspective based on the cervical cancer model].
    Monsonego J.
    Gynecol Obstet Fertil; 2010 Apr 20; 38(4):250-4. PubMed ID: 20362481
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma.
    Khan S, Jaffer NN, Khan MN, Rai MA, Shafiq M, Ali A, Pervez S, Khan N, Aziz A, Ali SH.
    Int J Infect Dis; 2007 Jul 20; 11(4):313-7. PubMed ID: 17291804
    [Abstract] [Full Text] [Related]

  • 20. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.
    Arnheim Dahlström L, Andersson K, Luostarinen T, Thoresen S, Ögmundsdottír H, Tryggvadottír L, Wiklund F, Skare GB, Eklund C, Sjölin K, Jellum E, Koskela P, Wadell G, Lehtinen M, Dillner J.
    Cancer Epidemiol Biomarkers Prev; 2011 Dec 20; 20(12):2541-50. PubMed ID: 21994401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.